Changes in CD4+ cells mirna expression following exposure to HIV 1 Claudio Casoli

Similar documents
Stable changes in CD4 T lymphocyte mirna expression after exposure to HIV-1

Immunodeficiency. (2 of 2)

Complete Transcriptome Analysis of Latently Infected CD4 + T Cells

5. Over the last ten years, the proportion of HIV-infected persons who are women has: a. Increased b. Decreased c. Remained about the same 1

Oncolytic Viruses as a Potential Approach to Eliminate the HIV Reservoir

Human Immunodeficiency Virus

6/7/17. Immune cells. Co-evolution of innate and adaptive immunity. Importance of NK cells. Cells of innate(?) immune response

cure research HIV & AIDS

How HIV Causes Disease Prof. Bruce D. Walker

Duskova et al. BMC Infectious Diseases 2013, 13:250

Can HPV, cervical neoplasia or. HIV transmission?


Fayth K. Yoshimura, Ph.D. September 7, of 7 HIV - BASIC PROPERTIES

HIV Immunopathogenesis. Modeling the Immune System May 2, 2007

Effector Mechanisms of Cell-Mediated Immunity

HIV INFECTION: An Overview

Viral Genetics. BIT 220 Chapter 16

HIV-1 Subtypes: An Overview. Anna Maria Geretti Royal Free Hospital

Prevention of infection 2 : immunisation. How infection influences the host : viruses. Peter

Determinants of Immunogenicity and Tolerance. Abul K. Abbas, MD Department of Pathology University of California San Francisco

MID 36. Cell. HIV Life Cycle. HIV Diagnosis and Pathogenesis. HIV-1 Virion HIV Entry. Life Cycle of HIV HIV Entry. Scott M. Hammer, M.D.

ARV Mode of Action. Mode of Action. Mode of Action NRTI. Immunopaedia.org.za

Immunity and Infection. Chapter 17

Learning Objectives. New HIV Testing Algorithm from CDC. Overview of HIV infection and disease 3/15/2016

LESSON 4.6 WORKBOOK. Designing an antiviral drug The challenge of HIV

Cerebrospinal Fluid EBV Replication is Associated with Compartmental Inflammation and Pleocytosis in HIV-positive naïve and Treated Individuals

Identification and Characterization of CD4 T cells actively transcribing HIV RNA in Peripheral Blood

Hepatitis virus immunity. Mar 9, 2005 Rehermann and Nascimbeni review Crispe review

Helminth worm, Schistosomiasis Trypanosomes, sleeping sickness Pneumocystis carinii. Ringworm fungus HIV Influenza

The Alphabet Soup of Viral Hepatitis Testing

HIV & AIDS: Overview

Allergy and Immunology Review Corner: Chapter 13 of Immunology IV: Clinical Applications in Health and Disease, by Joseph A. Bellanti, MD.

Micropathology Ltd. University of Warwick Science Park, Venture Centre, Sir William Lyons Road, Coventry CV4 7EZ

Completing the CIBMTR Confirmation of HLA Typing Form (Form 2005)

ACQUIRED IMMUNODEFICIENCY SYNDROME AND ITS OCULAR COMPLICATIONS

Chapter 19: The Genetics of Viruses and Bacteria

Effector mechanisms of cell-mediated immunity: Properties of effector, memory and regulatory T cells

Sysmex Educational Enhancement and Development No

How do we measure HIV drug resistance. Monique Nijhuis

October 26, Lecture Readings. Vesicular Trafficking, Secretory Pathway, HIV Assembly and Exit from Cell

Centers for Disease Control August 9, 2004

Molecular Diagnosis Future Directions

Transcription and RNA processing

HIV Basics: Clinical Tests and Guidelines

Antiviral Chemotherapy

Page 32 AP Biology: 2013 Exam Review CONCEPT 6 REGULATION

Overview of role of immunologic markers in HIV diagnosis

Fig. 1: Schematic diagram of basic structure of HIV

EMERGING ISSUES IN THE HUMORAL IMMUNE RESPONSE TO HIV. (Summary of the recommendations from an Enterprise Working Group)

Antigen Presentation and T Lymphocyte Activation. Abul K. Abbas UCSF. FOCiS

Intrinsic cellular defenses against virus infection

With over 20 drugs and several viable regimens, the mo6vated pa6ent with life- long access to therapy can control HIV indefinitely, elimina6ng the

Molecular Detection of Chemokine Ligand 3 Like-1 (CCL3L1, Mip-1αp or LD78β) Gene Copy Number Amongst HIV-1 Positive

HIV Diagnostic Testing

Major Histocompatibility Complex (MHC) and T Cell Receptors

VIRUSES. 1. Describe the structure of a virus by completing the following chart.

RAISON D ETRE OF THE IMMUNE SYSTEM:

Therapeutic Immunization with Autologous DC Pulsed with Autologous Inactivated HIV-1 Infected Apoptotic Cells

SYSTEMS BIOLOGY APPROACHES TO IDENTIFY MECHANISMS OF IMMUNE MEDIATED PROTECTION TRANSLATING RESEARCH INTO HEALTH

Transcription and RNA processing

Official Journal of the European Communities COMMISSION

MedChem 401~ Retroviridae. Retroviridae

MID-TERM EXAMINATION

Effect of 24 Week Intensification with a CCR5-Antagonist on the Decay of the HIV-1 Latent Reservoir

Immunological Tolerance

Rama Nada. - Malik

Building Better Therapeutics November 19, :10am

Significance of the MHC

SEVENTH EDITION CHAPTER

An Evolutionary Story about HIV

Chronic HIV-1 Infection Frequently Fails to Protect against Superinfection

Laboratory Testing for HIV Tropism

Current Strategies in HIV-1 Vaccine Development Using Replication-Defective Adenovirus as a Case Study

Section 6. Junaid Malek, M.D.

Lecture 11. Immunology and disease: parasite antigenic diversity

Sub-Topic Classification of HIV related Opportunistic Infections. Miguel Anderson and Joseph Fonseca

Chapters 21-26: Selected Viral Pathogens

Pathogens and the immune system

MID 36. Cell. HIV Life Cycle. HIV Diagnosis and Pathogenesis. HIV-1 Virion HIV Entry. Life Cycle of HIV HIV Entry. Scott M. Hammer, M.D.

Principles of Adaptive Immunity

Viruses and cancer: Should we be more afraid?

A VACCINE FOR HIV BIOE 301 LECTURE 10 MITALI BANERJEE HAART

Hepatitis B Antiviral Drug Development Multi-Marker Screening Assay

1. Engineering Foot-and-Mouth Disease Viruses with Improved

Trends in molecular diagnostics

Lecture 2 Evolution in action: the HIV virus

Effects on Immune Function of Therapeutic Immunization with HIV-1 1 Tat: Interim Results of a Randomized Trial


HIV Diagnosis and Pathogenesis. HIV-1 Virion

Week 5 Section. Junaid Malek, M.D.

Analysis of Massively Parallel Sequencing Data Application of Illumina Sequencing to the Genetics of Human Cancers

The Biology and Genetics of Cells and Organisms The Biology of Cancer

CD90 + Human Dermal Stromal Cells Are Potent Inducers of FoxP3 + Regulatory T Cells

Viral Hepatitis Diagnosis and Management

Pediatric HIV Cure Research

Scott Abrams, Ph.D. Professor of Oncology, x4375 Kuby Immunology SEVENTH EDITION

Laboratory diagnostics CH/HIV/0052/17/10/2017

INTERNATIONAL CONFERENCE ON HARMONISATION OF TECHNICAL REQUIREMENTS FOR REGISTRATION OF PHARMACEUTICALS FOR HUMAN USE. ICH Considerations

Bachelor Biomedical Sciences Utrecht University. Anouk Schuren

Transcription:

Changes in CD4+ cells mirna expression following exposure to HIV 1 Claudio Casoli University of Milan

Rationale There is evidence that mirnas can modulate host innate immunity against viruses. Specifically for HIV 1, it has been demonstrated that mirnas can regulate viral gene expression by decreasing PCAF expression and promoting HIV 1 latency or by directly targeting HIV 1 messengers (Triboulet R. et al. Science 315, 1579 82; 2007). Until now, five cellular mirnas have been identified to recognize HIV 1 messengers which are up regulated in only resting CD4+ T cells (Huang J. et al. Nature Medicine 13, 1241 7; 2007). However, cellular mirnas expression may also favour HIV 1 infection (Han Y. et al. Nature Medicine; 2007).

Objectives of this study To study if mirna change is related to immune response or HIV-1 replication. To propose new approaches in investigating HIV- 1/host interactions.

Population study The HIV-related mirna expression was assessed in CD4+ cells. Three patient groups were studied: a. subjects classified as éltnp (n 7) b. subjects naive for antiretroviral therapy (n 10) c. subjects who were multiply sexually exposed to HIV but remained uninfected for at least 4 years, named MEU (n 7) No occurrence of a specific phenotype that restricts HIV-1 susceptibility (CCR5 32 allele, CCR5 and CCR2 polymorphisms, CCL3L1 copy number, HLA class II alleles). None of the subjects had co-infection such as HBV, HCV, HTLV. These subjects were characterized on the basis of cellular and molecular phenotype (CD38, HLA-DR, sjtrec, Treg), proviral load quantification and mirna expression.

Methodology Expression levels of 377 mirnas were obtained using real time quantitative polymerase chain reaction based arrays (1 card for 1 patient, data obtained in 2 independent experiments). To analyse data we chose 2 - Ct method, which relates the PCR signal of patient cell mirna transcripts to that of normal cells collected from a pool of 6 healthy donors. Criteria for comparison: - Replication in more than 70% of the individuals in at least one of the three patient classes; - Variation at least of 1 log10 in either direction (up or down).

Viro immunological features of HIV 1+ patients As expected, éltnp had fewer peripheral activated T lymphocytes in comparison with those of naive patients. No significant differences were observed between éltnp and naive patients by analysis of the differentiation marker CD127 expression in either virgin or memory T cells. Moreover, éltnp had fewer regulatory T cells that expressed an activation marker such as HLA-DR, a higher number of sjtrec+ cells, and a lower amount of intracellular HIV-1 DNA within CD4+ T lymphocytes than naive individuals.

Could mirnas be considered as markers of HIV 1 exposure or infection? Analysis of 377 mirnas expression demonstrated that 8 are altered in all groups. - 5 of which are down-regulated and 3 are up-regulated. - This alteration may be interpreted as a signature of HIV exposure or infection.

Could mirnas distinguish HIV 1 exposure from infection? This heat map of single pattern subjects shows two hierarchical groups: one is related to uninfected MEU subjects, while the second group is related to infected patients. The MEU group shows a prevalent mirnas downregulation, whereas Naive and éltnp subjects show a prevalent mirnas upregulation.

Are the differences in mirna profiles significant? 29 mirnas are differentially expressed between groups. These findings confirm the results shown in the hierarchical analysis.

Can Dicer and Drosha expressions explain the mirna profiles observed in patients? Both enzymes resulted significantly downregulated in MEU subjects in comparison to infected patients. Only in MEU subjects the mirna expression is strictly correlated to enzyme expression. Each class of individuals is characterized by similar levels of Dicer and Drosha. None of them seem to play a predominant role.

Which are the mirna involved in HIV 1 replication or immune response? Out of 377 mirnas tested, only a few are implicated in HIV replication and immune response. Among these, some (like 34a and 125a-3p) distinguish infected from uninfected patients in HIV replication and immune response, respectively. In addition, 23a and 155 mirnas characterize Naive from the other two groups. In the MEU group, most of the mirnas involved in the control of the immune response are down-regulated.

Does in vitro exposure of healthy CD4+ T lymphocytes to gp120 induce changes in mirna expression? + mab r gp120 LAI gp120 11 17 141 11 14 UP 23 15 0 68 DOWN When the gp120 action was neutralized Exposure to recombinant and natural with a specific mab, many mirnas show molecules induced the same alteration the same expression as in non-exposed in 60% of mirnas. cells. The different molecular structure of Presumably the expression of these gp120 used could explain the different mirnas could be altered by gp120 mirnas expressed. through the CD4 binding signalling.

Which mirnas are similarly altered after gp120 exposure and in vitro infection? 5 out of 23 mirnas, which expression may be related to CD4/gp120 binding site, were also found altered after in vitro infection with X4 strain. Of note these mirnas (34c-5p, 518f, 452, 202, 487b) showed the same expression levels in both conditions (gp120 exposure and in vitro infection). Can these mirnas modulate HIV entry?

Conclusions - mirnas discriminate infected from uninfected subjects. - A signature of HIV exposure may be defined. - There is no difference between mirna profiles of Naive and éltnp groups. -Only exposure to HIV is enough to induce a marked alteration of mirna patterns and consequently may influence immune function of CD4+ T cells. -Thus a mirna pattern may reflect a change in the immune system.

Personnel and Institutions involved in the research University of Milan Claudio Casoli Fabio Bignami Paola Ronzi Massimo Galli University of Parma Mariolina Gulli Nelson Marmiroli Roberta Ruotolo San Raffaele Fondation Lucia Lopalco University of Modena and Reggio Emilia Andrea Cossarizza Linda Bertoncelli Marcello Pinti Cristina Mussini Arcispedale S. Maria Nuova of Reggio Emilia Giacomo Magnani Anlaids Lombardia Elisabetta Pilotti